Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study – Reuters

Pfizer and BioNTech’s jointly developed COVID-19 vaccine was successful in neutralizing a new variant of the coronavirus spreading rapidly in Brazil, Reuters reports, citing the findings of a study conducted by scientists from the companies and the University of Texas Medical Branch.

more to come ....